business development

Pharma

AZ leans on cancer, rare disease muscle in solid Q2

In 2026’s second quarter, AstraZeneca generated revenue of nearly $15.4 million, growing 5% over the same period in 2025 at constant currencies.

Fraiser Kansteiner Jul 27, 2026 10:21am

Sanofi

Sanofi announces limited changes to its revamped executive team

Jul 21, 2026 1:35pm

Pfizer

Fierce Biotech

A 5-month sprint: Inside Pfizer's $10B deal with Innovent

Jun 21, 2026 10:41pm

Astellas

Inside Astellas CEO's plan to counter Xtandi's patent cliff

Jun 11, 2026 6:00pm

handshake deal shake hand arrows ok yes

Novavax bets on ‘amplification strategy’ with Sanofi, Pfizer deals

Apr 6, 2026 8:37am

Lundbeck

After Avadel setback, Lundbeck signals future M&A rigor

Jan 22, 2026 11:13am